publication venue for
- Treatment of pouchitis, Crohn's disease, cuffitis, and other inflammatory disorders of the pouch: consensus guidelines from the International Ileal Pouch Consortium. 2021
- Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: a single-arm, open-label, phase 2 trial.. 7. 2022
- Efficacy of soluble fibre, antispasmodic drugs, and gut-brain neuromodulators in irritable bowel syndrome: a systematic review and network meta-analysis.. 5. 2019
- Safety and activity of ivosidenib in patients with IDH1-mutant advanced cholangiocarcinoma: a phase 1 study.. 4. 2019
- Patient-reported outcomes with sofosbuvir and velpatasvir with or without ribavirin for hepatitis C virus-related decompensated cirrhosis: an exploratory analysis from the randomised, open-label ASTRAL-4 phase 3 trial.. 1. 2016
- A step towards informed positioning of advanced therapies for moderate-to-severe Crohn's disease. 2021
- Oesophageal manometry with a solid test meal: ready for prime time? 2017
- Management of pouch neoplasia: consensus guidelines from the International Ileal Pouch Consortium. 2022
- Methods and indicators to validate country reductions in incidence of hepatitis C virus infection to elimination levels set by WHO. 2022
- Diagnosis and classification of ileal pouch disorders: consensus guidelines from the International Ileal Pouch Consortium. 2021
- Efficacy of drugs in chronic idiopathic constipation: a systematic review and network meta-analysis. 2019